Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antigen-presenting cell receptors mediating uptake of mite allergens refers to a functional group of pattern recognition receptors (PRRs) primarily expressed on dendritic cells and macrophages that recognize and internalize allergens from house dust mites (HDM), such as Dermatophagoides pteronyssinus. The most prominent members of this group are C-type lectin receptors (CLRs), including the Mannose Receptor (CD206), DC-SIGN (CD209), and Dectin-2 (CLEC6A), which bind to carbohydrate moieties on allergens like Der p 1 and Der p 2 (Willart et al., 2012, J Clin Invest; Barrett et al., 2009, J Immunol). Additionally, Der p 2 can act as a functional mimic of MD-2, facilitating the activation of Toll-like receptor 4 (TLR4) (Trompette et al., 2009, Nature). These receptors are critical for the initiation of the allergic cascade, as they mediate the endocytosis, processing, and subsequent presentation of allergen-derived peptides to naive T cells, promoting a Th2-biased immune response. This Th2 polarization leads to the production of IgE and the recruitment of eosinophils, driving the pathogenesis of allergic asthma and rhinitis (Hammad & Lambrecht, 2008, Nat Rev Immunol). While no drugs currently target these receptors exclusively in clinical practice, they are significant targets for research into novel immunotherapies and glycan-based inhibitors designed to block allergen uptake and induce immune tolerance.
Competitive inhibition of allergen binding to C-type lectin receptors, modulation of dendritic cell-mediated T-cell polarization, and induction of peripheral T-cell tolerance through allergen immunotherapy.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen-presenting cell receptors mediating uptake of mite allergens.